OBJECTIVE: To enable serodiscordant couples to reproduce while minimizing the risk of infecting the female partner and to demonstrate the feasibility of including these couples in an insemination program. DESIGN: Prospective follow-up study. SETTING: Ambulatory IUIs. PATIENT(S): Fifty-six HIV-1-serodiscordant couples with a male infected partner. INTERVENTION(S): Sperm cell separation by the gradient density method followed by the swim-up method, virological detection, and IUI after ovarian stimulation. MAIN OUTCOME MEASURE(S): Pregnancy rate, HIV-1 test, and p24 antigenemia in women. RESULT(S): Two hundred thirteen IUIs were performed, and 37 pregnancies occurred, resulting in 33 births and 2 ongoing pregnancies. Fifty percent of couples have a child. No women were infected. CONCLUSION(S): Our study demonstrates the efficiency of an IUI program with prepared and virologically tested spermatozoa in serodiscordant couples with an HIV-1-infected male partner, allowing the couples to have children without transmission of the virus to the female partner.
OBJECTIVE: To enable serodiscordant couples to reproduce while minimizing the risk of infecting the female partner and to demonstrate the feasibility of including these couples in an insemination program. DESIGN: Prospective follow-up study. SETTING: Ambulatory IUIs. PATIENT(S): Fifty-six HIV-1-serodiscordant couples with a male infected partner. INTERVENTION(S): Sperm cell separation by the gradient density method followed by the swim-up method, virological detection, and IUI after ovarian stimulation. MAIN OUTCOME MEASURE(S): Pregnancy rate, HIV-1 test, and p24 antigenemia in women. RESULT(S): Two hundred thirteen IUIs were performed, and 37 pregnancies occurred, resulting in 33 births and 2 ongoing pregnancies. Fifty percent of couples have a child. No women were infected. CONCLUSION(S): Our study demonstrates the efficiency of an IUI program with prepared and virologically tested spermatozoa in serodiscordant couples with an HIV-1-infected male partner, allowing the couples to have children without transmission of the virus to the female partner.
Authors: Rachelle J Chadwick; Joanne E Mantell; Jennifer Moodley; Jane Harries; Virginia Zweigenthal; Diane Cooper Journal: Top Antivir Med Date: 2011-11
Authors: Maryam Zafer; Hacsi Horvath; Okeoma Mmeje; Sheryl van der Poel; Augusto E Semprini; George Rutherford; Joelle Brown Journal: Fertil Steril Date: 2015-12-11 Impact factor: 7.329